欧林生物
(688319)
| 流通市值：115.42亿 | | | 总市值：115.51亿 |
| 流通股本：4.05亿 | | | 总股本：4.06亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 246,608,575.54 | 169,670,167.26 | 184,322,268.85 | 191,476,245.44 |
| 交易性金融资产 | 2,600,000 | 47,600,000 | 17,600,000 | 22,600,000 |
| 应收票据及应收账款 | 655,974,993.78 | 665,082,511.8 | 617,274,832.43 | 555,335,585.58 |
| 其中：应收票据 | 404,608.88 | 168,000 | 160,800 | 3,662,084.03 |
| 应收账款 | 655,570,384.9 | 664,914,511.8 | 617,114,032.43 | 551,673,501.55 |
| 预付款项 | 6,569,598.04 | 9,384,798.72 | 8,961,806.4 | 5,947,422.33 |
| 其他应收款合计 | 2,575,050.67 | 2,623,482.62 | 2,344,537.99 | 2,018,317.37 |
| 存货 | 62,383,250.35 | 68,803,356.79 | 76,037,389.4 | 85,147,611.63 |
| 其他流动资产 | 19,622,044.56 | 1,059,401.37 | 1,662,731.38 | 1,953,408.36 |
| 流动资产合计 | 996,333,512.94 | 964,223,718.56 | 908,203,566.45 | 864,478,590.71 |
| 非流动资产: | | | | |
| 固定资产 | 393,016,663.17 | 390,396,357.92 | 366,904,216.12 | 364,288,189.66 |
| 在建工程 | 226,258,725.96 | 200,612,663.22 | 217,503,452.63 | 217,036,543.13 |
| 使用权资产 | 11,395,862.02 | 12,476,293.36 | 10,939,570.96 | 615,931.15 |
| 无形资产 | 16,899,398.35 | 17,242,138.35 | 17,581,416.83 | 16,029,636.95 |
| 开发支出 | 348,555,954.62 | 330,915,866.8 | 289,366,717.64 | 285,288,006.29 |
| 长期待摊费用 | 5,486,226.17 | 5,809,678.74 | 6,836,586.34 | 7,868,559.93 |
| 递延所得税资产 | 24,905,439.79 | 22,715,457.93 | 18,206,740.39 | 18,206,740.39 |
| 其他非流动资产 | 218,000 | 577,465 | 691,823.5 | 218,000 |
| 非流动资产合计 | 1,026,736,270.08 | 980,745,921.32 | 928,030,524.41 | 909,551,607.5 |
| 资产总计 | 2,023,069,783.02 | 1,944,969,639.88 | 1,836,234,090.86 | 1,774,030,198.21 |
| 流动负债: | | | | |
| 短期借款 | 30,000,000 | 20,000,000 | 20,000,000 | 19,200,000 |
| 应付票据及应付账款 | 153,068,762.45 | 116,333,283.38 | 86,434,331.35 | 79,866,745.99 |
| 应付账款 | 153,068,762.45 | 116,333,283.38 | 86,434,331.35 | 79,866,745.99 |
| 合同负债 | 986,426.8 | 2,115,824.76 | 622,059.22 | 2,025,587.38 |
| 应付职工薪酬 | 16,116,721.98 | 434,378 | 425,203.95 | 426,394.51 |
| 应交税费 | 3,644,755.72 | 9,116,387.4 | 5,857,039.16 | 8,260,158.88 |
| 其他应付款合计 | 461,171,494.02 | 405,672,924.18 | 383,476,126.74 | 347,106,925.55 |
| 一年内到期的非流动负债 | 72,055,470.64 | 78,698,512.22 | 65,950,965.17 | 81,350,000 |
| 其他流动负债 | 29,592.8 | 18,032.24 | 18,661.78 | 60,767.62 |
| 流动负债合计 | 737,073,224.41 | 632,389,342.18 | 562,784,387.37 | 538,296,579.93 |
| 非流动负债: | | | | |
| 长期借款 | 323,716,528.4 | 289,331,528.4 | 304,241,528.4 | 278,501,528.4 |
| 租赁负债 | 7,258,321.88 | 8,646,041.99 | 7,343,844.31 | 656,852.67 |
| 预计负债 | 13,484,801.75 | 11,653,604.32 | 1,736,448.67 | 744,706.38 |
| 递延收益 | 29,162,620.24 | 26,354,964.63 | 23,249,309.02 | 25,002,055.84 |
| 递延所得税负债 | 8,394,587.42 | 8,255,815.87 | 2,458,748.62 | 2,458,748.62 |
| 非流动负债合计 | 382,016,859.69 | 344,241,955.21 | 339,029,879.02 | 307,363,891.91 |
| 负债合计 | 1,119,090,084.1 | 976,631,297.39 | 901,814,266.39 | 845,660,471.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 405,708,900 | 405,933,600 | 405,933,600 | 405,933,600 |
| 资本公积 | 560,578,168.37 | 593,690,397.97 | 593,690,397.97 | 607,911,623.63 |
| 减:库存股 | 3,172,764 | 5,561,325 | 5,561,325 | 5,561,325 |
| 盈余公积 | 18,192,083.14 | 14,198,275.26 | 14,198,275.26 | 14,198,275.26 |
| 未分配利润 | -77,627,668.73 | -48,414,233.4 | -82,697,109.91 | -102,967,913.16 |
| 归属于母公司股东权益合计 | 903,678,718.78 | 959,846,714.83 | 925,563,838.32 | 919,514,260.73 |
| 少数股东权益 | 300,980.14 | 8,491,627.66 | 8,855,986.15 | 8,855,465.64 |
| 股东权益合计 | 903,979,698.92 | 968,338,342.49 | 934,419,824.47 | 928,369,726.37 |
| 负债和股东权益合计 | 2,023,069,783.02 | 1,944,969,639.88 | 1,836,234,090.86 | 1,774,030,198.21 |
| 公告日期 | 2026-03-31 | 2025-10-30 | 2025-08-29 | 2025-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |